The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
MHC class I expression and outcomes in breast cancer in the real-world clinico-genomic data and the FinXX trial.
 
Yi Liu
No Relationships to Disclose
 
Sachin Kumar Deshmukh
Employment - Caris Life Sciences
 
Yaohua Ma
No Relationships to Disclose
 
Jodi Carter
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca
 
Sharon Wu
Employment - Caris Life Sciences
Research Funding - Caris Life Sciences
 
Joanne Xiu
Employment - Caris Life Sciences
 
Nadine Norton
No Relationships to Disclose
 
Kathryn Ruddy
Research Funding - Medtronic (I)
Patents, Royalties, Other Intellectual Property - Spouse and Mayo Clinic have filed patents related to the application of artificial intelligence to the electrocardiogram for diagnosis and risk stratification. (I)
 
Edith Perez
Employment - Bolt Biotherapeutics; Genentech
Leadership - Bolt Biotherapeutics
Consulting or Advisory Role - Daiichi Sankyo; Puma Biotechnology; Seagen
 
Shipra Gandhi
Honoraria - Aptitude Health; OncLive/MJH Life Sciences
Consulting or Advisory Role - AstraZeneca; Hologic/Biotheranostics; MedPage Today; Novartis; Peerview
Speakers' Bureau - Roche
Travel, Accommodations, Expenses - MJH Life Sciences; Roche
 
Priscila Barreto Coelho
No Relationships to Disclose
 
Maryam Lustberg
Honoraria - Novartis
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Lilly; Menarini; Novartis; Osmol Therapeutics; Pfizer
Speakers' Bureau - Lilly
Other Relationship - Cynosure/Hologic
 
Matthew Goetz
Consulting or Advisory Role - ARC Therapeutics (Inst); ARC Therapeutics (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Atossa Therapeutics (Inst); BeiGene (Inst); bioTheranostics (Inst); BioTheryX; Biovica (Inst); Blueprint Medicines (Inst); Context Therapeutics (Inst); Eagle Pharmaceuticals (Inst); eChinaHealth (Inst); EcoR1 Capital (Inst); Engage Health Media (Inst); Genentech (Inst); Genomic Health (Inst); Genzyme (Inst); Genzyme (Inst); Incyclix Bio (Inst); Intellisphere (Inst); Laekna Therapeutics; Lilly (Inst); Loxo (Inst); Novartis (Inst); Puma Biotechnology (Inst); Rna Diagnostics (Inst); Seagen (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst); Sermonix Pharmaceuticals (Inst); Tersera
Research Funding - AstraZeneca (Inst); Atossa Genetics (Inst); BioTheryX (Inst); Lilly (Inst); Loxo (Inst); Pfizer (Inst); Sermonix Pharmaceuticals (Inst); SimBioSys (Inst)
Travel, Accommodations, Expenses - Lilly (Inst)
(OPTIONAL) Uncompensated Relationships - Symbios
 
Heikki Joensuu
No Relationships to Disclose
 
George Sledge
Employment - Caris Life Sciences
Leadership - Caris Life Sciences; Syndax
Stock and Other Ownership Interests - Caris Life Sciences
Travel, Accommodations, Expenses - Caris Life Sciences
 
E Thompson
No Relationships to Disclose
 
Saranya Chumsri
Honoraria - Roche Thailand
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Athenex; Athenex; Axiom Healthcare Strategies; bioTheranostics; bioTheranostics (Inst); Cardinal Health; Cepton Strategies; Daiichi Sankyo/Astra Zeneca; Eisai; Equinox Group; Eradigm Consulting; Genentech; Gilead Sciences; Immunomedics; Immunomedics; Immunomedics; MDoutlook; Novartis; Novartis; Novartis (Inst); Puma Biotechnology; Seagen; Syndax
Research Funding - Array BioPharma; Briacell (Inst); Merck; Salix